4-(5-Bromopyridin-3-yl)-2,6-dichloropyrimidine

Catalog No. :
ACHYPE739
CAS No. :
2024646-57-7
Molecular Formula :
C9H4BrCl2N3
Molecular Weight :
304.96

IUPAC Name:4-(5-bromopyridin-3-yl)-2,6-dichloropyrimidine

4-(5-Bromopyridin-3-yl)-2,6-dichloropyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$402.00Login to see priceInquiryInquiry
100mg98%$592.00Login to see priceInquiryInquiry
250mg98%$834.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(5-Bromopyridin-3-yl)-2,6-dichloropyrimidine
IUPAC Name4-(5-bromopyridin-3-yl)-2,6-dichloropyrimidine
MDL No.MFCD28430896
Molecular FormulaC9H4BrCl2N3
Molecular Weight304.96
SMILESClC1=CC(C2=CC(Br)=CN=C2)=NC(Cl)=N1
InChI KeyQFSDOJVDTCQRLR-UHFFFAOYSA-N
Synonym4-(5-bromopyridin-3-yl)-2,6-dichloropyrimidine;4-(5-bromo-3-pyridinyl)-2,6-dichloro-Pyrimidine
CAS No.2024646-57-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACHYPE739 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKXJG657 route compound structure diagram
    ACKXJG6573764-01-0 In Stock
  2. Plus
  3. ACEYBL781 route compound structure diagram
    ACEYBL781452972-09-7 In Stock
  4. Then
  5. ACHYPE739 route product structure diagram
    ACHYPE7392024646-57-7
Inquiry

2. ACHYPE739 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPTOW753 route compound structure diagram
    ACPTOW753452972-13-3 In Stock
  2. Plus
  3. ACKXJG657 route compound structure diagram
    ACKXJG6573764-01-0 In Stock
  4. Then
  5. ACHYPE739 route product structure diagram
    ACHYPE7392024646-57-7
Inquiry

Comments (0)